debio 0123
hsc
['debio 0123', 'debio 0123 ', 'debiopharm']
excited to be working on one of the few wee1 inhibitors in development, an emerging anti-cancer drug class. our team presented a poster at esmo on the promising results on our wee1 inhibitor debio 0123 in patient biopsies from a phase 1 clinical trial. 
We are an independent biopharmaceutical company with an ongoing commitment to improve patient outcomes & quality of life in oncology & bacterial infections